Interestingly, the efficiency of direct repair mechanisms can influence the effectiveness of certain cancer treatments. For example, some chemotherapy drugs, like temozolomide, work by introducing DNA damage that rapidly dividing cancer cells cannot repair. However, high levels of MGMT in tumors can counteract the effects of these drugs, leading to treatment resistance. As a result, MGMT status is often evaluated to predict the response to alkylating agents in cancer therapy.
